| Nov 15 |
After Plunging -20% in 4 Weeks, Here's Why the Trend Might Reverse for Gossamer Bio (GOSS)
|
| Nov 14 |
After Plunging -15.92% in 4 Weeks, Here's Why the Trend Might Reverse for Gossamer Bio (GOSS)
|
| Nov 12 |
Industry Analysts Just Made A Sizeable Upgrade To Their Gossamer Bio, Inc. (NASDAQ:GOSS) Revenue Forecasts
|
| Nov 10 |
Gossamer Bio, Inc. (NASDAQ:GOSS) Just Reported And Analysts Have Been Lifting Their Price Targets
|
| Nov 8 |
Gossamer Bio GAAP EPS of -$0.14, revenue of $9.48M
|
| Nov 7 |
Gossamer Bio (GOSS) Reports Q3 Loss, Tops Revenue Estimates
|
| Nov 7 |
Gossamer Bio: Q3 Earnings Snapshot
|
| Nov 7 |
Gossamer Bio Announces Third Quarter 2024 Financial Results and Provides Business Update
|
| Oct 31 |
NRx Pharmaceuticals added to Emerging Growth Conference 76 on October 31 and Update to Schedule
|
| Oct 30 |
Presenting on the Emerging Growth Conference 76 Day 2 on October 31 Register Now
|
